FDA Adverse Event Injury Summary report: N

PROMUS ELEMENT PLUS EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM

MDR report key: 3072374 · Received April 23, 2013

Report

Report Number
2134265-2013-02456
Event Type
Injury
Date Received
April 23, 2013
Date of Event
March 22, 2013
Report Date
March 25, 2013
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P110010
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT. (B)(4). DEVICE EVALUATED BY MANUFACTURER - IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

SAME CASE AS MFR ID # 2134265-2013-02457, 2134265-2013-02458. IT WAS REPORTED THAT DURING A PERCUTANEOUS CORONARY INTERVENTION, STENT DAMAGE OCCURRED. THE TARGET LESION WAS LOCATED IN A SAPHENOUS VEIN GRAFT (SVG) TO THE RIGHT CORONARY ARTERY (RCA). A NON-BSC EMBOLIC PROTECTION DEVICE WAS PLACED IN THE DISTAL LESION. THREE UNKNOWN SIZE PROMUS ELEMENT PLUS STENTS WERE IMPLANTED. FOLLOWING DEPLOYMENT OF THE STENTS THE EMBOLIC PROTECTION DEVICE WAS WITHDRAWN AND CAUGHT ON THE DEPLOYED STENT STRUTS, ALL THREE IMPLANTED STENTS WERE DEFORMED. THE DEFORMED STENTS WERE POST-DILATED WITH A UNKNOWN BALLOON AND RESTORED BLOOD FLOW. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT STATUS IS FINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
174430 PROMUS ELEMENT PLUS EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC - MAPLE GROVE UNK717

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention EMBOLIC PROTECTION: SPIDER